In this edition of our newsletter, we are pleased to share the first study that systematically characterizes the impact of non-antibiotic drugs on a gut microbiome-like environment, while also showing that human-targeted drugs may increase antibiotic resistance. You will also find the first study to demonstrate that the ratio of genera Klebsiella and Bifidobacterium in early infancy could be used as a potential biomarker for allergy development later in childhood.

Next up is an article highlighting how the metabolic benefits of a carbohydrate-restricted diet in obese NAFLD patients may involve shifts in gut microbiota composition. And finally, a new study that concludes that Lactobacillus rhamnosus GG supplementation may partly modify meconium microbiota dysbiosis in neonates who are at high risk of asthma.

The GMFH publishing team